James Dahlman, associate professor in the Department of Biomedical Engineering at Georgia Tech and Emory University, discusses the delivery challenges of genetic medicines, how nanoparticles compare to viral vectors, and what it takes to develop new vectors that can deliver genetic medicines to where they need to go.